NSAIDs may raise risk of kidney injury in patients with diabetes
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.
Diabetes
Clinical briefs for Tuesday, Jan. 12
The COVID picture at 6 months: Symptoms patients face after leaving the hospital … New CDC study confirms community link to COVID rate in residents, staff … Nurse-led intervention encourages advance care planning discussions … COVID vaccination guidelines for diabetes types are conflicting … PPIs no more helpful than placebo for gastric reflux throat symptoms,…
All prediabetes is not alike: 6 subtypes help predict risk, prevent poor outcomes
A clear new classification of prediabetes subtypes can help clinicians identify their most at-risk patients and aid in developing targeted therapies to prevent progression to diabetes, researchers report.
FDA approves first generic of glucagon to treat severe low blood sugar
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
Clinical briefs for Monday, Dec. 7
Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized COVID patients … COVID antiviral pill trials move forward, long-term care component added … Interactive tool helps find your place in line for…
MedDiet cuts diabetes risk by a third in 25-year Women’s Health Study
The Mediterranean diet reduces diabetes risk by 30% in women who are considered clinically overweight or obese, a new analysis of long-term data finds.
Clinical briefs for Monday, Nov. 16
A few pounds of weight loss nearly halves diabetes risk, large-scale study finds … FDA: Only N95s are nearly 100% effective, but cloth masks also protective … Link between gut microbiome and risk of Alzheimer’s brain plaques confirmed … Long-term study finds walnut consumption may reduce heart disease risk … Heart failure drug succeeds in…
Among short-lived diabetes treatments, a combo therapy lasts
Dual treatment with the glucose-lowering drugs dapagliflozin and exenatide remains effective for patients with diabetes after two years of continual use, according to the results of a late-stage clinical trial.
A common diabetes medication may lower mortality risk among nursing home residents with COVID-19
A study involving hundreds of Veterans Affairs patients shows a link between the diabetes drug metformin and a lower risk of death from COVID-19.
Diabetes equipment payments, Medicare coverage would grow under new federal proposal
Nursing homes residents who use continuous glucose monitors (CGMs) to track their daily blood sugar levels would see their Medicare coverage and payments for the devices expanded under a new proposed rule by the federal government. The Centers for Medicare & Medicaid Services on Tuesday announced a proposal for several new changes to Medicare Durable…
